This is a blog dedicated to the recent news and updates on the diagnosis,treatment,surgery and research of Pancreatic Cancer
Monday, September 23, 2013
Common Surgical Problems In Clinical Practice Of A Private Community Hospital: When A Vogue Started By A Celebrity Confuse The Pu...
Common Surgical Problems In Clinical Practice Of A Private Community Hospital: When A Vogue Started By A Celebrity Confuse The Pu...: Surgeons Say Many Women Opt For Unnecessary Double Mastectomies, Following Angelina Jolie’s Example By Sarah Rae Fruchtnicht , Tue,...
Tuesday, September 17, 2013
Common Surgical Problems In Clinical Practice Of A Private Community Hospital: Don't Be Scared If Your Surgeon Is Wearing Google ...
Common Surgical Problems In Clinical Practice Of A Private Community Hospital: Don't Be Scared If Your Surgeon Is Wearing Google ...: For most people, Google Glass still seems like little more than a gimmick. But in health care, doctors are already finding uses for the ...
Sunday, September 15, 2013
Diet Quality Linked to Pancreatic Cancer Risk
By Veronica Hackethal
(Reuters Health) - In a large new study of older Americans, researchers find that people with the healthiest eating habits are about 15 percent less likely to develop pancreatic cancer than those with the poorest diets.
Tuesday, September 10, 2013
F.D.A. Approves a Drug for Late-Stage Pancreatic Cancer
The Food and Drug Administration on Friday approved Celgene’s drug Abraxane for use in treating advanced pancreatic cancer, supplementing the thin arsenal available to fight the disease.
In a clinical trial, Abraxane prolonged the lives of patients by a little less than two months on average. Pancreatic specialists have said the drug was a welcome, if modest, advance against a disease that is extremely tough to treat.
http://www.nytimes.com/2013/09/07/business/fda-approves-drug-for-late-stage-pancreatic-cancer.html?smid=pl-share
In a clinical trial, Abraxane prolonged the lives of patients by a little less than two months on average. Pancreatic specialists have said the drug was a welcome, if modest, advance against a disease that is extremely tough to treat.
http://www.nytimes.com/2013/09/07/business/fda-approves-drug-for-late-stage-pancreatic-cancer.html?smid=pl-share
Monday, September 2, 2013
Common Surgical Problems In Clinical Practice: Giant Skin Cyst
Common Surgical Problems In Clinical Practice: Giant Skin Cyst: Sometimes a large tumor can still be benign.What is required is merely excision of the tumor without wide excision of the adjacent nor...
Common Surgical Problems In Clinical Practice: The profile of Gallbladder stones
Common Surgical Problems In Clinical Practice: The profile of Gallbladder stones: This is a typical specimen of an inflamed gallbladder packed with pigmented cholesterol gallstones removed from a patient who has been su...
Common Surgical Problems In Clinical Practice: Internal Biliary Stenting at ERCP before Laparosco...
Common Surgical Problems In Clinical Practice: Internal Biliary Stenting at ERCP before Laparosco...: Many patients with gallstones neglect or ignore their symptoms by taking painkillers. Many patients seek treatment from Primary Care Ph...
Subscribe to:
Posts (Atom)